Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome

X. Li, Y. Chen, L. Wang, G. Shang, C. Zhang, Z. Zhao, H. Zhang, A. Liu

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Quercetin shows protective effects against hepatopulmonary syndrome (HPS), as demonstrated in a rat model. However, whether these effects involve pulmonary vascular angiogenesis in HPS remains unclear. Therefore, this study aimed to assess the effect of quercetin on pulmonary vascular angiogenesis and explore the underlying mechanisms. Male Sprague-Dawley rats weighing 200-250 g underwent sham operation or common bile duct ligation (CBDL). Two weeks after surgery, HIF-1α and NFkB levels were assessed in rat lung tissue by immunohistochemistry and western blot. Then, CBDL and sham-operated rats were further divided into 2 subgroups each to receive intraperitoneal administration of quercetin (50 mg/kg daily) or 0.2% Tween for two weeks: Sham (Sham+Tween; n=8), CBDL (CBDL+Tween; n=8), Q (Sham+quercetin; n=8), and CBDL+Q (CBDL+ quercetin; n=8). After treatment, lung tissue specimens were assessed for protein (immunohistochemistry and western blot) and/or gene expression (quantitative real-time PCR) levels of relevant disease markers, including VEGFA, VEGFR2, Akt/p-Akt, HIF-1α, vWf, and IκB/p-IκB. Finally, arterial blood was analyzed for alveolar arterial oxygen pressure gradient (AaPO2). Two weeks after CBDL, HIF-1a expression in the lung decreased, but was gradually restored at four weeks. Treatment with quercetin did not significantly alter HIF-1α levels, but did reduce AaPO2as well as lung tissue NF-κB activity, VEGFA gene and protein levels, Akt activity, and angiogenesis. Although hypoxia is an important feature in HPS, our findings suggest that HIF-1α was not the main cause for the VEGFA increase. Interestingly, quercetin inhibited pulmonary vascular angiogenesis in rats with HPS, with involvement of Akt/NF-κB and VEGFA/VEGFR-2 pathways.

Original languageEnglish
Article numbere5326
JournalBrazilian Journal of Medical and Biological Research
Volume49
Issue number7
DOIs
Publication statusPublished - Jul 4 2016

Fingerprint

Hepatopulmonary Syndrome
Quercetin
Common Bile Duct
Rats
Ducts
Ligation
Lung
Polysorbates
Blood Vessels
Tissue
Western Blotting
Immunohistochemistry
Vascular Endothelial Growth Factor Receptor-2
Weighing
Pressure gradient
Gene expression
Surgery
Sprague Dawley Rats
Real-Time Polymerase Chain Reaction
Arterial Pressure

Keywords

  • Angiogenesis
  • Hepatopulmonary syndrome
  • HIF-1α
  • Quercetin

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biophysics
  • Immunology
  • Medicine(all)
  • Physiology
  • Biochemistry
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Cell Biology

Cite this

Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. / Li, X.; Chen, Y.; Wang, L.; Shang, G.; Zhang, C.; Zhao, Z.; Zhang, H.; Liu, A.

In: Brazilian Journal of Medical and Biological Research, Vol. 49, No. 7, e5326, 04.07.2016.

Research output: Contribution to journalArticle

Li, X. ; Chen, Y. ; Wang, L. ; Shang, G. ; Zhang, C. ; Zhao, Z. ; Zhang, H. ; Liu, A. / Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. In: Brazilian Journal of Medical and Biological Research. 2016 ; Vol. 49, No. 7.
@article{c91e4c5eba9a4e4fbb62d91400714776,
title = "Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome",
abstract = "Quercetin shows protective effects against hepatopulmonary syndrome (HPS), as demonstrated in a rat model. However, whether these effects involve pulmonary vascular angiogenesis in HPS remains unclear. Therefore, this study aimed to assess the effect of quercetin on pulmonary vascular angiogenesis and explore the underlying mechanisms. Male Sprague-Dawley rats weighing 200-250 g underwent sham operation or common bile duct ligation (CBDL). Two weeks after surgery, HIF-1α and NFkB levels were assessed in rat lung tissue by immunohistochemistry and western blot. Then, CBDL and sham-operated rats were further divided into 2 subgroups each to receive intraperitoneal administration of quercetin (50 mg/kg daily) or 0.2{\%} Tween for two weeks: Sham (Sham+Tween; n=8), CBDL (CBDL+Tween; n=8), Q (Sham+quercetin; n=8), and CBDL+Q (CBDL+ quercetin; n=8). After treatment, lung tissue specimens were assessed for protein (immunohistochemistry and western blot) and/or gene expression (quantitative real-time PCR) levels of relevant disease markers, including VEGFA, VEGFR2, Akt/p-Akt, HIF-1α, vWf, and IκB/p-IκB. Finally, arterial blood was analyzed for alveolar arterial oxygen pressure gradient (AaPO2). Two weeks after CBDL, HIF-1a expression in the lung decreased, but was gradually restored at four weeks. Treatment with quercetin did not significantly alter HIF-1α levels, but did reduce AaPO2as well as lung tissue NF-κB activity, VEGFA gene and protein levels, Akt activity, and angiogenesis. Although hypoxia is an important feature in HPS, our findings suggest that HIF-1α was not the main cause for the VEGFA increase. Interestingly, quercetin inhibited pulmonary vascular angiogenesis in rats with HPS, with involvement of Akt/NF-κB and VEGFA/VEGFR-2 pathways.",
keywords = "Angiogenesis, Hepatopulmonary syndrome, HIF-1α, Quercetin",
author = "X. Li and Y. Chen and L. Wang and G. Shang and C. Zhang and Z. Zhao and H. Zhang and A. Liu",
year = "2016",
month = "7",
day = "4",
doi = "10.1590/1414-431X20165326",
language = "English",
volume = "49",
journal = "Brazilian Journal of Medical and Biological Research",
issn = "0100-879X",
publisher = "Associacao Brasileira de Divulgacao Cientifica",
number = "7",

}

TY - JOUR

T1 - Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome

AU - Li, X.

AU - Chen, Y.

AU - Wang, L.

AU - Shang, G.

AU - Zhang, C.

AU - Zhao, Z.

AU - Zhang, H.

AU - Liu, A.

PY - 2016/7/4

Y1 - 2016/7/4

N2 - Quercetin shows protective effects against hepatopulmonary syndrome (HPS), as demonstrated in a rat model. However, whether these effects involve pulmonary vascular angiogenesis in HPS remains unclear. Therefore, this study aimed to assess the effect of quercetin on pulmonary vascular angiogenesis and explore the underlying mechanisms. Male Sprague-Dawley rats weighing 200-250 g underwent sham operation or common bile duct ligation (CBDL). Two weeks after surgery, HIF-1α and NFkB levels were assessed in rat lung tissue by immunohistochemistry and western blot. Then, CBDL and sham-operated rats were further divided into 2 subgroups each to receive intraperitoneal administration of quercetin (50 mg/kg daily) or 0.2% Tween for two weeks: Sham (Sham+Tween; n=8), CBDL (CBDL+Tween; n=8), Q (Sham+quercetin; n=8), and CBDL+Q (CBDL+ quercetin; n=8). After treatment, lung tissue specimens were assessed for protein (immunohistochemistry and western blot) and/or gene expression (quantitative real-time PCR) levels of relevant disease markers, including VEGFA, VEGFR2, Akt/p-Akt, HIF-1α, vWf, and IκB/p-IκB. Finally, arterial blood was analyzed for alveolar arterial oxygen pressure gradient (AaPO2). Two weeks after CBDL, HIF-1a expression in the lung decreased, but was gradually restored at four weeks. Treatment with quercetin did not significantly alter HIF-1α levels, but did reduce AaPO2as well as lung tissue NF-κB activity, VEGFA gene and protein levels, Akt activity, and angiogenesis. Although hypoxia is an important feature in HPS, our findings suggest that HIF-1α was not the main cause for the VEGFA increase. Interestingly, quercetin inhibited pulmonary vascular angiogenesis in rats with HPS, with involvement of Akt/NF-κB and VEGFA/VEGFR-2 pathways.

AB - Quercetin shows protective effects against hepatopulmonary syndrome (HPS), as demonstrated in a rat model. However, whether these effects involve pulmonary vascular angiogenesis in HPS remains unclear. Therefore, this study aimed to assess the effect of quercetin on pulmonary vascular angiogenesis and explore the underlying mechanisms. Male Sprague-Dawley rats weighing 200-250 g underwent sham operation or common bile duct ligation (CBDL). Two weeks after surgery, HIF-1α and NFkB levels were assessed in rat lung tissue by immunohistochemistry and western blot. Then, CBDL and sham-operated rats were further divided into 2 subgroups each to receive intraperitoneal administration of quercetin (50 mg/kg daily) or 0.2% Tween for two weeks: Sham (Sham+Tween; n=8), CBDL (CBDL+Tween; n=8), Q (Sham+quercetin; n=8), and CBDL+Q (CBDL+ quercetin; n=8). After treatment, lung tissue specimens were assessed for protein (immunohistochemistry and western blot) and/or gene expression (quantitative real-time PCR) levels of relevant disease markers, including VEGFA, VEGFR2, Akt/p-Akt, HIF-1α, vWf, and IκB/p-IκB. Finally, arterial blood was analyzed for alveolar arterial oxygen pressure gradient (AaPO2). Two weeks after CBDL, HIF-1a expression in the lung decreased, but was gradually restored at four weeks. Treatment with quercetin did not significantly alter HIF-1α levels, but did reduce AaPO2as well as lung tissue NF-κB activity, VEGFA gene and protein levels, Akt activity, and angiogenesis. Although hypoxia is an important feature in HPS, our findings suggest that HIF-1α was not the main cause for the VEGFA increase. Interestingly, quercetin inhibited pulmonary vascular angiogenesis in rats with HPS, with involvement of Akt/NF-κB and VEGFA/VEGFR-2 pathways.

KW - Angiogenesis

KW - Hepatopulmonary syndrome

KW - HIF-1α

KW - Quercetin

UR - http://www.scopus.com/inward/record.url?scp=84978969857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978969857&partnerID=8YFLogxK

U2 - 10.1590/1414-431X20165326

DO - 10.1590/1414-431X20165326

M3 - Article

C2 - 27383124

AN - SCOPUS:84978969857

VL - 49

JO - Brazilian Journal of Medical and Biological Research

JF - Brazilian Journal of Medical and Biological Research

SN - 0100-879X

IS - 7

M1 - e5326

ER -